Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial von Lordick, Florian, Prof, Kang, Yoon-Koo, Prof, Chung, Hyun-Cheol, Prof, Salman, Pamela, MD, Oh, Sang Cheul, Prof, Bodoky, György, Prof, Kurteva, Galina, MD, Volovat, Constantin, MD, Moiseyenko, Vladimir M, Prof, Gorbunova, Vera, Prof, Park, Joon Oh, MD, Sawaki, Akira, MD, Celik, Ilhan, Prof, Götte, Heiko, PhD, Melezínková, Helena, MD, Moehler, Markus, Prof

Volltext

Tumor acidity: From hallmark of cancer to target of treatment von Bogdanov, Alexey, Bogdanov, Andrey, Chubenko, Viacheslav, Volkov, Nikita, Moiseenko, Fedor, Moiseyenko, Vladimir

Volltext

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study... von VAN CUTSEM, Eric, MOISEYENKO, Vladimir M, RISSE, Marie-Laure, AJANI, Jaffer A, TJULANDIN, Sergei, MAJLIS, Alejandro, CONSTENLA, Manuel, BONI, Corrado, RODRIGUES, Adriano, FODOR, Miguel, CHAO, Yee, VOZNYI, Edouard

Volltext

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treat... von VAN CUTSEM, Eric, TABERNERO, Josep, MCKENDRICK, Joe, POLIKOFF, Jonathan, TELLIER, Alexia, CASTAN, Rémi, ALLEGRA, Carmen, LAKOMY, Radek, PRENEN, Hans, PRAUSOVA, Jana, MACARULLA, Teresa, RUFF, Paul, HAZEL, Guy A. Van, MOISEYENKO, Vladimir, FERRY, David

Volltext

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial von AJANI, Jaffer A, RODRIGUEZ, Wuilbert, BODOKY, Gyorgy, MOISEYENKO, Vladimir, LICHINITSER, Mikhail, GORBUNOVA, Vera, VYNNYCHENKO, Ihor, GARIN, August, LANG, Istvan, FALCON, Silvia

Volltext

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup an... von Tabernero, Josep, Van Cutsem, Eric, Lakomý, Radek, Prausová, Jana, Ruff, Paul, van Hazel, Guy A, Moiseyenko, Vladimir M, Ferry, David R, McKendrick, Joseph J, Soussan-Lazard, Karen, Chevalier, Soazig, Allegra, Carmen J

Volltext

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial von Stebbing, Justin, Prof, Baranau, Yauheni, MD, Baryash, Valeriy, MD, Manikhas, Alexey, MD, Moiseyenko, Vladimir, Prof, Dzagnidze, Giorgi, MD, Zhavrid, Edvard, Prof, Boliukh, Dmytro, MD, Stroyakovskii, Daniil, MD, Pikiel, Joanna, MD, Eniu, Alexandru, MD, Komov, Dmitry, MD, Morar-Bolba, Gabriela, MD, Li, Rubi K, MD, Rusyn, Andriy, Prof, Lee, Sang Joon, PhD, Lee, Sung Young, MS, Esteva, Francisco J, Prof

Volltext

Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance von Moiseenko, Fedor, Bogdanov, Alexey, Egorenkov, Vitaliy, Volkov, Nikita, Moiseyenko, Vladimir

Volltext

Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcino... von AJANI, Jaffer A, MOISEYENKO, Vladimir M, AWAD, Lucile, VAN CUTSEM, Eric, TJULANDIN, Sergei, MAJLIS, Alejandro, CONSTENLA, Manuel, BONI, Corrado, RODRIGUES, Adriano, FODOR, Miguel, CHAO, Yee, VOZNYI, Edouard

Volltext

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenoca... von AJANI, Jaffer A, MOISEYENKO, Vladimir M, MARABOTTI, Cindy, VAN CUTSEM, Eric, TJULANDIN, Sergei, MAJLIS, Alejandro, CONSTENLA, Manuel, BONI, Corrado, RODRIGUES, Adriano, FODOR, Miguel, CHAO, Yee, VOZNYI, Edouard

Volltext

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial von Stebbing, Justin, Baranau, Yauheni V., Baryash, Valery, Manikhas, Alexey, Moiseyenko, Vladimir, Dzagnidze, Giorgi, Zhavrid, Edvard, Boliukh, Dmytro, Pikiel, Joanna, Eniu, Alexandru E., Li, Rubi K., Tiangco, Beatrice, Lee, Sang Joon, Kim, Sunghyun

Volltext

Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation von Moiseyenko, Fedor V., Egorenkov, Vitaliy V., Kramchaninov, Mikhail M., Artemieva, Elizaveta V., Aleksakhina, Svetlana N., Holmatov, Maxim M., Moiseyenko, Vladimir M., Imyanitov, Evgeny N.

Volltext

Tumor alkalization therapy: misconception or good therapeutics perspective? - the case of malignant ascites von Bogdanov, Alexey, Verlov, Nikolay, Bogdanov, Andrey, Burdakov, Vladimir, Semiletov, Valeriy, Egorenkov, Vitaliy, Volkov, Nikita, Moiseyenko, Vladimir

Volltext

Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Bre... von Sokolenko, Anna P, Moiseyenko, Fedor V, Iyevleva, Aglaya G, Ivantsov, Alexandr O, Dolmatov, Georgiy D, Shelekhova, Ksenia V, Gulo, Elizaveta V, Topal, Anastasya X, Artemieva, Elizaveta V, Abduloeva, Nuriniso H, Rysev, Nikita A, Barsova, Daria A, Levchenko, Natalia V, Volkov, Nikita M, Egorenkov, Vitaliy V, Moiseyenko, Vladimir M, Imyanitov, Evgeny N

Volltext

Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants von Mitiushkina, Natalia V., Tiurin, Vladislav I., Iyevleva, Aglaya G., Kholmatov, Maxim M., Filippova, Elena A., Moiseyenko, Fedor V., Levchenko, Nikita E., Sardaryan, Ivan S., Odintsova, Svetlana V., Lozhkina, Alexandra M., Volkov, Nikita M., Karaseva, Nina A., Moiseyenko, Vladimir M., Orlov, Sergey V., Imyanitov, Evgeny N.

Volltext

Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer von Volkov, Nikita M., Yanus, Grigoriy A., Ivantsov, Alexandr O., Moiseenko, Fedor V., Matorina, Olga G., Bizin, Ilya V., Moiseyenko, Vladimir M., Imyanitov, Evgeny N.

Volltext

Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models von Terterov, Ivan N., Chubenko, Vyacheslav A., Knyazev, Nikolay A., Klimenko, Vladimir V., Bogdanov, Andrei A., Moiseyenko, Vladimir M., Bogdanov, Alexey A.

Volltext

Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or Gastroesophageal Adenocarcin... von AJANI, Jaffer A, FODOR, Miguel B, TJULANDIN, Sergei A, MOISEYENKO, Vladimir M, CHAO, Yee, CABRAL FILHO, Sebastiao, MAJLIS, Alejandro, ASSADOURIAN, Sylvie, VAN CUTSEM, Eric

Volltext

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results von O'SHAUGHNESSY, Joyce, MILES, David, TWELVES, Chris, VAN HAZEL, Guy, VERMA, Shailendra, LEONARD, Robert, VUKELJA, Svetislava, MOISEYENKO, Vladimir, AYOUB, Jean-Pierre, CERVANTES, Guadalupe, FUMOLEAU, Pierre, JONES, Stephen, LUI, Wing-Yiu, MAURIAC, Louis

Volltext

Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion [version 1; peer review: 2 approved, 1 approved with reservations] von Moiseenko, Fedor V, Volkov, Nikita, Bogdanov, Alexey, Dubina, Michael, Moiseyenko, Vladimir

Volltext